# Fulcrum Therapeutics Inc. (FULC) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$85M |
| 2024 | -$22M |
| 2023 | -$111M |
| 2022 | -$113M |
| 2021 | -$81M |
| 2020 | -$72M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2025-09-30 | -$22M |
| 2025-06-30 | -$20M |
| 2024-09-30 | -$25M |
| 2024-06-30 | $52M |
| 2024-03-31 | -$30M |
| 2023-09-30 | -$27M |
| 2023-06-30 | -$27M |
| 2023-03-31 | -$28M |
| 2022-09-30 | -$24M |
| 2022-06-30 | -$34M |
| 2022-03-31 | -$26M |
| 2021-09-30 | -$21M |
| 2021-06-30 | -$20M |
| 2021-03-31 | -$17M |
| 2020-09-30 | -$19M |
| 2020-06-30 | -$16M |
| 2020-03-31 | -$19M |

Source: [CompaniesByCap](https://companiesbycap.com/company/FULC/operating-income)